CERVICAL TOTAL DISC REPLACEMENT DEVICE MARKET ANALYSIS

Market Challenges And Opportunities

Increasing product approvals by the U.S. Food and Drug Administration

Increasing organic strategies such as product approvals by the U.S. FDA is expected to propel the market growth during the forecast period. For instance, in July 2022, Centinel Spine, Inc. announced the U.S. Food and Drug Administration (FDA) Pre-Market Application (PMA) approval of 1-level indications for three additional cervical total disc replacement (TDR) devices: prodisc C Vivo, prodisc C Nova, and prodisc C SK. Prodisc C Vivo has keel-less endplates including a convex, superior endplate to match more concave vertebral anatomy, while prodisc C SK and prodisc C Nova implant designs have flat endplates with low-profile keels to better match flat vertebral anatomy.

Global Cervical Total Disc Replacement Device Market: Restraint

High rates of complications and rehospitalizations after cervical disc replacement surgery

High rates of complications and rehospitalizations after cervical disc replacement surgery can hinder the market growth over the forecast period. For instance, in March 2020, National Center for Biotechnology Information published a data according to which there are high rate of certain complications after the cervical disc replacement surgeries (CDR). In the first postoperative year following CDR, mechanical and/or bone-related complications were the most prevalent (reported in 12.3% of patients), and they included implant mispositioning, heterotrophic ossification, and neighboring disc degeneration. Moreover, 4% of CDR patients required further surgery as a result of device misalignment, migration, subsidence, or persistent discomfort. At 4 years after surgery, a second meta-analysis reported a 7.4% incidence of neck discomfort, implant migration, or radiculopathy which is going to impede the growth of cervical disc replacement device market during the forecast period. But the high rates of complications in hospitals  and rehospitalization after the surgery can be avoided by proper care after the surgery.

Restraints

High rates of complications and rehospitalizations after cervical disc replacement surgery

High rates of complications and rehospitalizations after cervical disc replacement surgery can hinder the market growth over the forecast period. For instance, in March 2020, National Center for Biotechnology Information published a data according to which there are high rate of certain complications after the cervical disc replacement surgeries (CDR). In the first postoperative year following CDR, mechanical and/or bone-related complications were the most prevalent (reported in 12.3% of patients), and they included implant mispositioning, heterotrophic ossification, and neighboring disc degeneration. Moreover, 4% of CDR patients required further surgery as a result of device misalignment, migration, subsidence, or persistent discomfort. At 4 years after surgery, a second meta-analysis reported a 7.4% incidence of neck discomfort, implant migration, or radiculopathy which is going to impede the growth of cervical disc replacement device market during the forecast period. But the high rates of complications in hospitals  and rehospitalization after the surgery can be avoided by proper care after the surgery.